Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Sell

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$42.17
Market Cap
1.42B
Sector
Health Care
Div. Growth
-
P/E
108.3
P/B
7.94
P/S
12.76
Dividend %
-
P/CF
18.5
P/FCF
194.1
Op. Cash Flow
12.5K
FCF
0.2
Op. Margin
16.60%
Net Margin
11.90%
ROE
7.80%
ROI
6.00%
ROA
4.60%
EPS Growth
59.00%
Current Ratio
8.7
Debt/Equity
56.50%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Palatin Technologies, Inc. (PTN) $0.44 - - 62.6M Strong Buy
Alere Inc (ALR) $50.39 - - 4.38B Strong Buy
Momenta Pharmaceuticals, Inc. (MNTA) $17.25 - - 1.27B Strong Buy
Pernix Therapeutics Holdings I (PTX) $4.49 - - 40.4M Strong Buy
Lannett Company, Inc. (LCI) $21.75 - - 763.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More